Figure 2

LH serology according to the diagnosis. ^# (p < 0.05), ^##(p < 0.01) statistically significant difference between a group of patients at the time of cancer diagnosis (Pre-Tx) and 2 months after the end of anticancer treatment (Post-Tx).